Suppr超能文献

初次和再次切除结直肠肝转移后长期预后和生活质量:一项回顾性分析。

Long-term outcome and quality of life after initial and repeat resection of colorectal liver metastasis: A retrospective analysis.

机构信息

Department of General, Visceral and Transplantation Surgery, RWTH Aachen University Hospital, Pauwelsstr. 30, 52074 Aachen, Germany.

Department of General, Visceral and Transplantation Surgery, RWTH Aachen University Hospital, Pauwelsstr. 30, 52074 Aachen, Germany.

出版信息

Int J Surg. 2017 Dec;48:281-285. doi: 10.1016/j.ijsu.2017.11.032. Epub 2017 Nov 23.

Abstract

BACKGROUND

Repeat hepatectomy is a widely accepted treatment for patients with recurrent colorectal liver metastasis (CRLM). The aim of this study was to compare initial and repeat hepatic resection concerning overall survival, prognostic factors and postoperative quality of life.

METHODS

Data on patients who underwent initial or repeat hepatic resection for CRLM between 2010 and 2016 were prospectively collected and retrospectively evaluated. Follow-up data, EORTC QLQ-C30 and QLQ-LMC21 questionnaire results for quality of life (QoL) evaluation were analyzed.

RESULTS

160 patients at a median age of 62.8 ± 11.8 years were analyzed. 122 were initially resected and 38 underwent a repeat hepatic resection. Disease-free survival (DSF) was superior in the initial resection group (p < 0.001), while there was no difference in overall survival (OS) (p = 0.288). BMI >30 (p = 0.012), extrahepatic tumor manifestation (p = 0.037), >1 CRLM manifestation (p = 0.009), and perioperative chemotherapy (p = 0.006) in the initial resection group and primary left colon tumor (p = 0.001) in the repeat resection group were identified as prognostic factors in multivariate Cox regression analysis. EORTC QLQ-LMC-21 module symptom score displayed an increased occurrence of a dry mouth in the initial hepatectomy group (p = 0.003). EORTC QLQ-C30 general functioning and symptom scores showed no difference.

CONCLUSION

Repeat hepatic resection for CRLM is as effective as primary surgical treatment in terms of OS and QoL. Patients should be selected carefully concerning prognostic factors as DFS is decreased after repeat hepatic resection.

摘要

背景

再次肝切除术是治疗结直肠癌肝转移(CRLM)复发患者的广泛接受的治疗方法。本研究的目的是比较初始和再次肝切除在总生存率、预后因素和术后生活质量方面的差异。

方法

前瞻性收集 2010 年至 2016 年间接受初始或再次肝切除术治疗 CRLM 的患者数据,并进行回顾性评估。分析随访数据、EORTC QLQ-C30 和 QLQ-LMC21 问卷结果,以评估生活质量(QoL)。

结果

共分析了 160 名中位年龄为 62.8±11.8 岁的患者。122 例患者接受了初始切除术,38 例患者接受了再次肝切除术。无复发生存(DFS)在初始切除术组中更优(p<0.001),而总生存率(OS)无差异(p=0.288)。BMI>30(p=0.012)、肝外肿瘤表现(p=0.037)、>1 个 CRLM 表现(p=0.009)和围手术期化疗(p=0.006)在初始切除术组和原发性左结肠癌(p=0.001)在再次切除术组中被确定为多变量 Cox 回归分析的预后因素。EORTC QLQ-LMC-21 模块症状评分显示初始肝切除组口干发生率增加(p=0.003)。EORTC QLQ-C30 一般功能和症状评分无差异。

结论

再次肝切除术治疗 CRLM 的效果与原发性手术治疗相当,在 OS 和 QoL 方面。考虑到 DFS 在再次肝切除后降低,应根据预后因素仔细选择患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验